NCT00255567View on ClinicalTrials.gov

Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,142

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Visceral Leishmaniasis
Interventions
DRUG

Sodium Stibogluconate

Sodium Stibogluconate 20mg/kg/day for 30 days

DRUG

Paromomycin sulphate

Paromomycin sulphate

DRUG

SSG and Paromomycin sulphate

SSG and Paromomycin Sulphate 17 days

Trial Locations (5)

Unknown

Arba Minch Hospital, Arba Minch

Gondar hospital, Gonder

KEMRI, Nairobi

Kassab Hospital, Kassāb

Amudat Hospital, Amudat

All Listed Sponsors
lead

Drugs for Neglected Diseases

OTHER

NCT00255567 - Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis | Biotech Hunter | Biotech Hunter